CDNA

CareDx, Inc.

9.73 USD

Last updated Nov 30, 23:55 UTC

Yesterday HIGH

$10.33

Yesterday LOW

$9.71

52w HIGH

$18.04

52w LOW

$4.8

EPS

-0.18

PE

-54.06

Next Earnings

Feb 26, 2024

Overview News Government Trades

CareDx, Inc. stock is up 79.85% since 30 days ago. The next earnings date is Feb 26, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 November’s closed higher than October. 100% of analysts rate it a buy.

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients. AlloSeq Tx, a high-resolution HLA typing solution, is used to type human leukocyte antigen (HLA) alleles.

Stock Exchange

NASDAQ

Sector

Services

Industry

Healthcare

Headquarters

Brisbane, United States Of America

Website

caredx.com

Benzinga Insights

Tue Aug 8, 2023

Earnings Scheduled For August 8, 2023

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
Benzinga Insights

Mon Aug 7, 2023

CareDx Earnings Preview
Happy Mohamed

Mon Aug 7, 2023

CareDx Announces District Court Judge Bars Natera From Falsely Advertising And Overstating The Scientific Performance Of Its Prospera Transplant Test

CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and
Lisa Levin

Wed Aug 2, 2023

Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Lisa Levin

Wed Aug 2, 2023

Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session.
Benzinga Newsdesk

Tue Jul 25, 2023

CareDx Acquires MediGO; Terms Not Disclosed

The company expects to expand o expand its digital health portfolio to serve the organ procurement organization (OPO) market while also bolstering its pre-transplant offerings aimed at shortening transplant wait
Benzinga Newsdesk

Mon Jul 17, 2023

Natera Says Court Issued Favorable Ruling In False Advertising Trial Against CareDx; Eliminates All Damages

The decision also noted that CareDx showed no evidence that any person was deceived by or relied on any of the advertisements at issue in the case.Separately, the jury's March 2022 verdict that CareDx engaged in
Benzinga Newsdesk

Tue Jul 11, 2023

Raymond James Maintains Market Perform on CareDxto Market Perform

Raymond James analyst Andrew Cooper maintains CareDx (NASDAQ:CDNA) from Market Perform to Market Perform.
Lisa Levin

Tue Jul 11, 2023

WD-40, Shutterstock And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
Lisa Levin

Mon Jul 10, 2023

Top 5 Health Care Stocks That May Collapse This Quarter

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.